- Press Room
- About the Committee
- Bill Status
- Hearings & Testimony
- Full Committee
- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
- Commerce, Justice, Science, and Related Agencies
- Defense
- Energy and Water Development
- Financial Services and General Government
- Homeland Security
- Interior, Environment, and Related Agencies
- Labor, Health and Human Services, Education, and Related Agencies
- Legislative Branch
- Military Construction, Veteran Affairs, and Related Agencies
- State, Foreign Operations, and Related Programs
- Transportation, Housing and Urban Development, and Related Agencies
- Legislation
- Subcommittees
- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
- Commerce, Justice, Science, and Related Agencies
- Defense
- Energy and Water Development
- Financial Services and General Government
- Homeland Security
- Interior, Environment, and Related Agencies
- Labor, Health and Human Services, Education, and Related Agencies
- Legislative Branch
- Military Construction, Veteran Affairs, and Related Agencies
- State, Foreign Operations, and Related Programs
- Transportation, Housing and Urban Development, and Related Agencies
- Republican Page
Hearing to Discuss the FDA's Review Process for products to treat rare diseases and neglected tropical diseases.
For Immediate Release:
June 23, 2010
Hearing to Discuss the FDA's Review Process for products to treat rare diseases and neglected tropical diseases.
More Information
Webcasts
Files
- Testimony of Dr. Christopher P. Austin, Director of the Chemical Genomics Center and Senior Advisor to the Director for Translational Research, National Institutes of Health
- Testimony of Dr. Emil Kakkis, President and Founder, Kakkis EveryLife Foundation
- Testimony of Dr. Jesse Goodman, Chief Scientist and Deputy Commissioner for Science and Public Health, Food and Drug Administration
- Testimony of Mr. Thomas Bollyky, Visiting Fellow, Center for Global Development
- Testimony of Ms. Diane Edquist Dorman, Vice President for Public Policy, National Organization for Rare Disorders
- Testimony of Ms. Gloria Steele, Senior Deputy Assistant Administrator for Global Health, USAID
